Summary

This study assessed the safety and tolerability of high doses of coenzyme Q10 (CoQ10) in amyotrophic lateral sclerosis (ALS).
CoQ10 may improve the mitochondrial dysfunction in ALS. The researchers found that CoQ10 was safe and well tolerated in 31 patients treated with doses as high as 3,000 mg/day for 8 months.

Further details can be found in the study.

References

John Cha, M Waheed Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath

 

Link to article >>